Chen J-Y, Xu L-F, Hu H-L, Wen Y-Q, Chen D, Liu W-H
Department of Urology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Eur Rev Med Pharmacol Sci. 2024 May;28(10):3476. doi: 10.26355/eurrev_202405_36279.
The article "MiRNA-215-5p alleviates the metastasis of prostate cancer by targeting PGK1", by J.-Y. Chen, L.-F. Xu, H.-L. Hu, Y.-Q. Wen, D. Chen, W.-H. Liu, published in Eur Rev Med Pharmacol Sci 2020; 24 (2): 639-646-DOI: 10.26355/eurrev_202001_20040-PMID: 32017004 has been retracted by the Editor in Chief. Following some concerns raised on PubPeer regarding a possible overlap in Figure 2C, the journal has started an investigation to assess the validity of the results as well as possible figure manipulation. The journal investigation revealed data and figure manipulation. For this reason, the Editor in Chief has decided to retract the manuscript. The authors have been informed about the retraction but remained unresponsive. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/20040.
J.-Y. 陈、L.-F. 徐、H.-L. 胡、Y.-Q. 温、D. 陈、W.-H. 刘发表于《欧洲医学与药理学评论》2020年；24 (2): 639 - 646 - DOI: 10.26355/eurrev_202001_20040 - PMID: 32017004的文章“MiRNA - 215 - 5p通过靶向PGK1减轻前列腺癌转移”已被主编撤回。在PubPeer上有人对图2C可能存在的重叠提出一些担忧后，该期刊已展开调查，以评估结果的有效性以及可能存在的图片处理问题。期刊调查发现了数据和图片处理问题。因此，主编决定撤回该稿件。已通知作者撤回事宜，但作者未作回应。本文已被撤回。出版商对由此可能造成的不便表示歉意。https://www.europeanreview.org/article/20040
